Home >> Cell Cycle >> Aurora Kinase >> Aurora Kinase Inhibitors >> 
United States (Change Country)

Barasertib (AZD1152-HQPA)

Catalog No. S1147 5 5 5 Customer Review(s) Product Citations7 Product Citation(s)
Price Availability Quantity
$ 120 Yes
$ 210 Yes
$ 670 Yes
 
processing...
Free Overnight Delivery on all orders over $ 500.

Order Barasertib (AZD1152-HQPA) now
and get it on

Barasertib (AZD1152-HQPA) Chemical Structure

Bio Information

Barasertib (AZD1152-HQPA) is a highly potent and selective Aurora B inhibitor with a Ki of 0.36 nM. Barasertib (AZD1152-HQPA) inhibits Aurora A with a Ki of 1.37 nM. AZD1152 is converted rapidly to the active Barasertib (AZD1152-HQPA) in plasma. Barasertib (AZD1152-HQPA) has a high specificity versus a panel of 50 other kinases. Consistent with inhibition of Aurora B kinase, addition of Barasertib (AZD1152-HQPA) to tumor cells in vitro induces chromosome misalignment, prevents cell division, and consequently reduces cell viability and induces apoptosis. [1][2][3]

References:

[1] Journal of Hepatology 2010;52:63–71

[3] Oncogene 2008;27:3244–3255

[2] haematologica 2008;93(5) :662-669

Chemical Information

Molecular Weight (WM): 507.56
Formula:

C26H30FN7O3

Solubility(R.T.:25°C): DMSO 102mg/mL 
Water <1mg/mL 
Ethanol 3mg/mL 

Quality Control

View current batch:
H-NMR HPLC

Recommended Screening Libraries

Related Inhibitors

Related Antibodies

Barasertib (AZD1152-HQPA) has been referenced in 7 publications.

A complex of Kif18b and MCAK promotes microtubule depolymerization and is negatively regulated by Aurora kinases.
System-level analysis of neuroblastoma tumor-initiating cells implicates AURKB as a novel drug target for neuroblastoma.
The induction of polyploidy or apoptosis by the Aurora A kinase inhibitor MK8745 is p53-dependent.
Aurora B interacts with NIR-p53, leading to p53 phosphorylation in its DNA-binding domain and subsequent functional suppression.
Localized Aurora B activity spatially controls non-kinetochore microtubules during spindle assembly.
Aurora kinase B/C inhibition impairs malignant glioma growth in vivo.
Canine osteosarcoma cells exhibit resistance to aurora kinase inhibitors.

We have 5 customer reviews of Barasertib (AZD1152-HQPA).

  • (5)
  • (0)
  • (0)
  • (0)
  • (0)
  • (0)
  • (0)
  • (0)
  • (0)

Average Customer Review

(5 customer reviews)
  • ;J Pharmacol Exp Ther, 2012, 343(3), 617-27
    Barasertib (AZD1152-HQPA) purchased from Selleck

  • ;Oncogene, 2012, 31, 1217–1227
    Barasertib (AZD1152-HQPA) purchased from Selleck

  • Data from [Clin Cancer Res 2010;16, 4572-4582]
    Barasertib (AZD1152-HQPA) purchased from Selleck

  • Data from [J Biol Chem 2011;286, 2236-44]
    Barasertib (AZD1152-HQPA) purchased from Selleck

  • ;Dr Gao Zhang of University of Pennsylvania
    Barasertib (AZD1152-HQPA) purchased from Selleck

Our scientific support team are available to answer any questions or queries.
Fill out an inquiry form for Barasertib (AZD1152-HQPA) for help.

Quality Matters

This product has been referenced in

Check our customer reviews


Click to enlarge

;J Pharmacol Exp Ther, 2012, 343(3), 617-27


Click to enlarge

;Oncogene, 2012, 31, 1217–1227

Your Recent History

Keywords:buy Barasertib (AZD1152-HQPA) | Barasertib (AZD1152-HQPA) supplier | purchase Barasertib (AZD1152-HQPA) | Barasertib (AZD1152-HQPA) cost | Barasertib (AZD1152-HQPA) manufacturer | order Barasertib (AZD1152-HQPA) | Barasertib (AZD1152-HQPA) distributor